Inhalation Science

Inhalation Risk Assessment

Estimate consumer-use inhalation exposure for sprays, powders, and room scenarios using chamber data and exposure models.

We combine measured aerosol and gas data with breathing assumptions and toxicology benchmarks to report margin of safety and scenario sensitivity.

ISO 17025OECD 412/413OSHA PEL / NIOSH RELEPA OPPT / OCSPPReviewed 2026-05-16
Request a quoteTalk to a scientist

Purpose & when to use

Inhalation Risk Assessment translates measured aerosol, particle size distribution (PSD), and gas-phase chamber data into scenario exposure estimates, intake, and margin of safety (MoS). We document assumptions under ISO 17025 quality controls and align benchmark selection to OSHA PEL, NIOSH REL, EPA OPPT/OCSPP, OECD 412/413, ICH Q9, or REACH inhalation DNEL frames when they fit the decision:

  1. Consumer spray exposure comparisons use chamber time series, PSD inputs, and OSHA PEL or NIOSH REL benchmarks to rank product modes under defined room-use scenarios.
  2. Room-applied aerosol safety reviews combine release-rate measurements, ventilation assumptions, and EPA OPPT/OCSPP exposure logic for label support or product-use limitations.
  3. Powder or dust scenario assessments pair particle-size data with breathing-rate assumptions and OECD 412/413 toxicology context to estimate intake and uncertainty drivers.
  4. Formulation or device change reviews use measured emissions, scenario sensitivity, and ICH Q9 risk framing to identify whether particle size, release rate, or duration drives MoS.
  5. International safety dossiers translate exposure outputs into REACH inhalation DNEL comparisons, with EPA and OECD context when relevant, for documented market-access communication.

Use this service when the decision depends on exposure under realistic use conditions, not emissions alone. The study plan defines scenarios, inputs, benchmarks, and uncertainty bounds before modeling begins, so each reported MoS can be traced back to measured data and declared assumptions.

Built for sprays, powders, rooms, and devices

Risk assessment is useful wherever emissions become an inhalation question: consumer aerosols, drug-delivery systems, respiratory protection, medical devices, air treatment units, and room-applied products.

  • Drug deliveryInhaled or intranasal products
  • Respiratory protectionMask and filter contexts
  • Medical devicesUse-related emissions
  • Air treatmentRoom-scale exposure scenarios
  • Spray aerosolConsumer and industrial sprays

Instrumentation & measurement ranges

Risk models are built from measured inputs first; scenario assumptions and toxicology benchmarks are documented beside the calculations.

0.3 – 20 µmparticle-size

Chamber particle and aerosol time series

Particle counts, PSD, and decay curves from chamber studies define airborne concentration over time, including peak and time-weighted values for each product-use condition.

0.001 ppm – 100 ppmconcentration

Gas and VOC analytical inputs

VOC, by-product, or gas measurements are incorporated when the inhalation question includes vapor-phase exposure as well as particle-phase aerosol or powder emissions.

1 – 120 minuse-duration

Scenario and breathing-rate model set

Room volume, ventilation, use duration, frequency, and breathing assumptions convert measured concentrations into intake or exposure estimates for defined users.

1 ratio – 1000 ratioMoS

Toxicology benchmark and MoS calculations

Benchmark inputs such as PEL, REL, DNEL, or study-derived points of departure are recorded with unit conversions and uncertainty factors before MoS is calculated.

Test method options

MethodStrengthsTradeoffAligned with
Screening scenario assessment (chamber data plus benchmarks)
  • Ranks products, use modes, or rooms using measured concentration data and OSHA PEL or NIOSH REL comparison points when occupational benchmarks fit.
  • Produces transparent MoS tables that show which assumption changes the result: release rate, room volume, ventilation, breathing rate, or use duration.
Screening assumptions can dominate the answer, so the output should guide decisions rather than replace a refined exposure assessment.
OSHA PEL / NIOSH REL
Refined time-series assessment (PSD and transient peaks)
  • Uses measured PSD and concentration time series to model peak, time-weighted, and size-informed inhalation exposure for sprays, powders, and device emissions.
  • Supports EPA OPPT/OCSPP consumer exposure logic and OECD 412/413 toxicology context when measured exposure needs a documented hazard benchmark.
Requires richer measurement datasets and more review time because size-resolved concentration, decay, and benchmark selection all need traceable documentation.
EPA OPPT / OCSPPOECD 412/413
Sensitivity and dossier support (MoS decision frame)
  • Maps ventilation, room size, frequency, duration, and benchmark choices to MoS sensitivity, supporting ICH Q9 risk-based decisions and change reviews.
  • Translates scenario outputs into REACH inhalation DNEL comparisons when downstream communication or international safety documentation needs a clear exposure basis.
Benchmark selection and uncertainty factors must be agreed before modeling, or the final MoS can appear precise while remaining decision-dependent.
ICH Q9REACH inhalation DNEL

Setup configurations

A useful inhalation risk assessment starts with scenario definition, not a spreadsheet. We confirm the product-use case, available measurement data, target population, benchmark source, and decision threshold before calculations begin. The setup items below define the inputs that make the final MoS traceable and reviewable:

Exposure profile

Use duration, frequency, distance from source, room volume, ventilation, and occupancy assumptions defined for each scenario before model runs begin.

Sample matrix

Particles, powders, droplets, gases, VOCs, or mixed-phase emissions identified so concentration data and benchmarks are applied to the correct hazard basis.

Flow & actuation profiles

Spray duration, actuation count, release rate, settling period, and breathing-rate assumptions documented for each user or room-use condition.

Calibration & verification

Source datasets checked for units, timestamps, calibration status, blanks, and conversion factors before they enter exposure or MoS calculations.

Chain of custody

Input files, calculation versions, benchmark references, and report tables controlled so each final result can be traced back to its source.

Compliance frame for inhalation risk assessment

The quality frame separates accredited laboratory controls from regulatory guidance used for model alignment. ISO 17025 governs the traceability of measured inputs; the remaining anchors guide benchmark selection and scenario logic.

  • ISO 17025AccreditedQuality-system control for measurement traceability, records, and technical review.
  • OECD 412/413AlignedRepeated-dose inhalation toxicology context for benchmark interpretation.
  • OSHA PEL / NIOSH RELAlignedOccupational exposure limits used when the scenario warrants comparison.
  • EPA OPPT / OCSPPAlignedConsumer and environmental exposure logic for relevant product categories.

Key data outputs & reporting

Inhalation risk assessment outputs are scenario-resolved, assumption-linked, and built for technical review. Reports include the measured input datasets used, exposure estimates by condition, MoS calculations, benchmark rationale, and sensitivity results for the assumptions that move the answer. Calculation tables preserve units, conversions, and source references so the path from chamber data to decision metric is visible.

Primary outputs

  • Exposure estimates by scenario, including peak and time-weighted concentration where the source data supports both views.
  • MoS calculations with benchmark selection, uncertainty factors, unit conversions, and assumption notes tied to each result.
  • Sensitivity tables showing which inputs drive risk: particle size, release rate, room volume, ventilation, breathing rate, or use duration.
  • Driver attribution and uncertainty discussion focused on the measurements and assumptions most likely to change the conclusion.

Deliverables

#FormatContents
01PDF reportMethods, scenarios, benchmark rationale, MoS tables, sensitivity discussion, and interpretation limits.
02CSV / XLSX datasetsCalculation tables, scenario inputs, unit conversions, and model outputs.
03FiguresScenario comparisons, MoS ranking plots, and sensitivity visuals for review packages.

QA / QC & data integrity

Risk-assessment quality depends on measurement traceability and calculation discipline across the full workflow from input review through reporting. We review source datasets, assumptions, units, and benchmark references before final interpretation, then preserve the calculation record so reviewers can audit how each exposure estimate and MoS value was produced.

Input-data review covering calibration status, units, timestamps, blanks, replicate handling, and measurement limits.

Calculation workbook version control with locked source tables and documented formula checks.

Benchmark-source documentation for each PEL, REL, DNEL, or toxicology point of departure used.

Scenario consistency review across room size, ventilation, use duration, frequency, and breathing-rate assumptions.

Independent technical review of units, conversions, uncertainty factors, and MoS interpretation before report release.

Why ARE Labs

ARE Labs connects technical topics to practical study design, method selection, controlled aerosol work, and reportable evidence without turning technical pages into sales pages.

Reviewed byJamie Balarashti (25 yrs - cascade & inhalation methods) - Weston Schaper (7 yrs - real-time sizing & nanoparticle work)
17025Accredited testing
900+Studies Performed
17+Years in operation
300+Clients supported

Common questions

Quick answers to the questions product safety, inhalation, consumer aerosol, and regulatory teams ask when scoping an inhalation risk assessment: what inputs are needed, how MoS is calculated, how room scenarios are compared, and how benchmark choices affect interpretation. Reach out if your product, exposure route, or benchmark frame does not match the scenarios below.

Q.Do you need chamber data to start?
A.Measured chamber data is preferred because it anchors the model. If no data exists, we can scope a screening assessment using documented assumptions, but we will label those results as assumption-driven.
Q.Can the assessment include particles and VOCs?
A.Yes. We can incorporate particle, droplet, powder, gas, or VOC inputs when the study has defensible measurements and appropriate benchmarks for each exposure component.
Q.What is margin of safety?
A.Margin of safety compares an estimated exposure with a selected benchmark or point of departure. The report documents the benchmark, units, uncertainty factors, and assumptions behind each MoS value.
Q.Can you model different rooms and ventilation rates?
A.Yes. Sensitivity runs commonly vary room volume, ventilation, duration, frequency, and breathing rate to identify the assumptions that most affect exposure and MoS.
Q.What do I receive?
A.You receive a PDF report, calculation tables, scenario inputs, MoS results, sensitivity figures, and a traceable explanation of benchmark choices and uncertainty drivers.

Standards & guidance

Inhalation risk assessment uses one accredited quality-system anchor and several aligned regulatory or toxicology frameworks. The correct set depends on product type, target population, market, benchmark availability, and decision threshold. These rows define the labels used in method alignment and the standards cards on this page so prose, methods, and compliance claims stay synchronized.

QA & Regulatory - Accredited

ISO 17025

Testing-laboratory quality system for method control, calibration traceability, records, and technical reviewView standard ->Exposure Benchmarks - Aligned

OSHA PEL / NIOSH REL

Occupational exposure-limit benchmarks used when workplace-style comparisons fit the inhalation scenarioView standard ->Consumer Exposure - Aligned

EPA OPPT / OCSPP

Consumer and environmental exposure assessment logic for chemicals, aerosols, and product-use scenariosView standard ->Toxicology - Aligned

OECD 412/413

Repeated-dose inhalation toxicology studies used to inform hazard context and benchmark selectionView standard ->QA & Regulatory - Aligned

ICH Q9

Quality risk management framing for scenario sensitivity, assumptions, and decision thresholdsView standard ->Exposure Benchmarks - Aligned

REACH inhalation DNEL

Derived no-effect level comparisons for international inhalation safety documentationView standard ->

Related services & devices

Service

Particle Size Distribution (PSD) Testing

Provides size-resolved particle inputs for inhalation models, especially when deposition or respirable fraction affects MoS.Read more ->Service

VOC and By-Product Emissions

Adds gas-phase concentration data when the risk assessment includes vapor exposure, odorants, or reaction by-products.Read more ->Service

Device Particle Emissions Testing

Supplies use-condition emission data for devices that release particles during operation, cleaning, heating, or airflow.Read more ->Devices

Drug Delivery Devices

Inhaled and intranasal products where emitted dose, aerosol size, and user breathing can affect exposure interpretation.Read more ->Devices

Respiratory

Masks, respirators, PAP devices, and breathing circuits where exposure estimates help compare protection scenarios.Read more ->Devices

Spray Aerosol

Consumer and industrial spray products where room volume, ventilation, duration, and droplet size drive inhalation exposure.Read more ->